50268-036-14 : NDC 2026 Code

50268-036-14 : Amantadine ( Amantadine )

Additionally :

You can get information about “50268-036-14” NDC code in 50268-036-14 in HTML format

HTML | 50268-036-14 in TXT (Plain Text) format

TXT | 50268-036-14 in PDF (Portable Document Format)

PDF | 50268-036-14 in XML format

XML formats.

NDC Code : 50268-036-14 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "50268-036-14",
    "PackageDescription": "40 TRAY in 1 CASE (50268-036-14)  / 10 CUP, UNIT-DOSE in 1 TRAY / 10 mL in 1 CUP, UNIT-DOSE (50268-036-11) ",
    "NDC11Code": "50268-0036-14",
    "ProductNDC": "50268-036",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Amantadine",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Amantadine",
    "DosageFormName": "SOLUTION",
    "RouteName": "ORAL",
    "StartMarketingDate": "20260119",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA075060",
    "LabelerName": "AvPAK",
    "SubstanceName": "AMANTADINE HYDROCHLORIDE",
    "StrengthNumber": "50",
    "StrengthUnit": "mg/5mL",
    "Pharm_Classes": "Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2026-01-21",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20271231",
    "StartMarketingDatePackage": "20260119",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}